Skip to Main Content

Paper Details

Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial.
Europace
7
2022
ABC, AF, Atrial fibrillation, CV death, Patients, SEE, atrial fibrillation, edoxaban, patient, patients, stroke, systemic embolic event, warfarin
Author NameAffiliation
Elliott M AntmanBrigham and Women's Hospital and Harvard Medical School
Eugene BraunwaldBrigham and Women's Hospital and Harvard Medical School
Robert P GiuglianoBrigham and Women's Hospital and Harvard Medical School
  • 1 - 3

Datasets

Release 1.2